Saturday 17 October 2026
Export PSNL’s income statement to Excel — free account
Personalis, Inc.
PSNL Healthcare Diagnostics & Research
Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
15.65
0.28
−1.76%
Follow PSNL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 3 | 3 |
| (43.70%) | (35.02%) | (41.35%) | (50.32%) | ||
| (30.61%) | (26.89%) | (31.92%) | (37.55%) | ||
ROIC |
(241.93%) | (259.21%) | (297.38%) | (317.48%) | |
Return on Tangible Assets |
(39.88%) | (29.75%) | (35.71%) | (43.35%) | |
Average Days of Receivables |
75.93 | 84.91 | 73.67 | 79.12 | |
Free Cash Flow per Share |
(0.75) | (0.89) | (0.81) | (0.96) | |
Free Cash Flow |
(66.17) | (79.45) | (84.53) | (100.85) | |
Capital Expenditures |
(5.67) | (4.50) | (5.06) | (8.56) | |
| Other line items | |||||
Cash ROIC |
(20.55%) | (15.85%) | (17.32%) | (22.52%) | |
Accounts Receivable Turnover |
4.96 | 5.72 | 5.38 | 5.56 | |
Accounts Payable Turnover |
4.30 | 5.56 | 5.41 | 4.69 | |
Inventory Turnover |
7.71 | 8.92 | 9.39 | 8.07 | |
Average Days of Payables |
80.29 | 88.01 | 83.12 | 96.03 | |
Days of Inventory on Hand |
33.54 | 41.63 | 45.44 | 57.83 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
70.45% | 72.17% | 80.85% | 80.55% | |
Selling, General and Administrative Expense of Revenue |
73.29% | 76.92% | 91.78% | 96.21% | |
Share Based Compensation of Revenue |
14.18% | 13.54% | 15.13% | 15.67% | |
Interest Coverage |
(582.04) | (429.55) | (457.69) | (536.66) | |
Operating CF/Net income |
0.82 | 0.92 | 0.83 | 0.86 | |
Depreciation/Fixed assets |
0.13 | 0.14 | 0.12 | 0.12 | |
Capex/Depreciation |
(0.92) | (0.74) | (0.87) | (1.49) | |
Revenue per Share |
0.78 | 0.78 | 0.62 | 0.66 | |
Operating CF per Share |
(0.68) | (0.84) | (0.76) | (0.88) | |
Capex per Share |
(0.06) | (0.05) | (0.05) | (0.08) | |
Capex to Sales |
0.08 | 0.06 | 0.08 | 0.12 |
Columns are period end dates